Selective Suppression of Cocaine- versus Food-Maintained Responding by Monoamine Releasers in Rhesus Monkeys: Benzylpiperazine, (+)Phenmetrazine, and 4-Benzylpiperidine
Authors:
- S. S. NegusSNS. S. Negus
- M. H. BaumannMBM. H. Baumann
- R. B. RothmanRRR. B. Rothman
- N. K. MelloNMN. K. Mello
- B. E. BloughBBB. E. Blough
- 1 April 2009
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 329 (1) , 272-281
Abstract
Monoamine releasers constitute one class of drugs currently under investigation as potential agonist medications for the treatment of cocaine dependence. The efficacy and safety of monoamine releasers as candidate medications may be influenced in part by their relative potency to release dopamine and serotonin, and we reported previously that releasers with approximately 30-fold selectivity for dopamine versus serotonin release may be especially promising. The present study examined the effects of the releasers benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine, which have 20- to 48-fold selectivity in vitro for releasing dopamine versus serotonin. In an assay of cocaine discrimination, rhesus monkeys were trained to discriminate 0.4 mg/kg i.m. cocaine from saline in a two-key, food-reinforced procedure. Each of the releasers produced a dose- and time-dependent substitution for cocaine. 4-Benzylpiperidine had the most rapid onset and shortest duration of action. Phenmetrazine and benzylpiperazine had slower onsets and longer durations of action. In an assay of cocaine self-administration, rhesus monkeys were trained to respond for cocaine injections and food pellets under a second order schedule. Treatment for 7 days with each of the releasers produced a dose-dependent and selective reduction in self-administration of cocaine (0.01 mg/kg/injection). The most selective effects were produced by phenmetrazine. Phenmetrazine also produced a downward shift in the cocaine self-administration dose effect curve, virtually eliminating responding maintained by a 30-fold range of cocaine doses (0.0032–0.1 mg/kg/injection) while having only small and transient effects on food-maintained responding. These findings support the potential utility of dopamine-selective releasers as candidate treatments for cocaine dependence.Keywords
This publication has 41 references indexed in Scilit:
- Cocaine effects during d-amphetamine maintenance: A human laboratory analysis of safety, tolerability and efficacyDrug and Alcohol Dependence, 2009
- Effects of the monoamine uptake inhibitors RTI-112 and RTI-113 on cocaine- and food-maintained responding in rhesus monkeysPharmacology Biochemistry and Behavior, 2008
- Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusersJournal of Psychopharmacology, 2008
- Controversies in translational research: drug self-administrationPsychopharmacology, 2008
- Dual dopamine/serotonin releasers as potential medications for stimulante and alcohol addictionsThe AAPS Journal, 2007
- Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeysEuropean Journal of Pharmacology, 2006
- Pharmacotherapy and other treatments for cocaine abuse and dependenceCurrent Opinion in Psychiatry, 2005
- Rapid Assessment of Choice between Cocaine and Food in Rhesus Monkeys: Effects of Environmental Manipulations and Treatment with d-Amphetamine and FlupenthixolNeuropsychopharmacology, 2002
- Preclinical Evaluation of Pharmacotherapies for Treatment of Cocaine and Opioid Abuse Using Drug Self-Administration ProceduresNeuropsychopharmacology, 1996
- Appetite SuppressantsDrugs, 1992